Review: Phenotypes and origins of myeloid-derived suppressor cells

A new review was published in Oncotarget's Volume 13 on November 17, 2022, entitled, "Myeloid-derived suppressor cells: Cancer, autoimmune diseases, and more."

Related Keywords

Japan ,Aizu ,Fukushima ,Nippon ,Daigo Yoshimori ,Kotaro Nanno ,Masahiko Shibata ,Satoshi Muto ,Yoshiyuki Suzuki ,Takashi Yazawa ,Kousaku Mimura ,Shungo Endo ,Takafumi Watanabe ,Takahiro Nakajima ,Seiichi Takenoshita ,Koji Kono ,Bange Kousei ,Makoto Takada ,Norio Inoue ,Kazunoshin Tachibana ,Aizu Oncology Consortium ,Nippon Medical School ,Lab Diagnostics Automation ,Fukushima Medical University ,Lab Diagnostics Automation Industry ,Automation Industry Focus ,Tomoyuki Momma ,Aizu Chuo Hospital ,Bange Kousei General Hospital ,Cancer ,Ancer Immunotherapy ,Hospital ,Immunosuppression ,Immunotherapy ,Alignant ,Obesity ,Ncology ,Research ,Humor ,